Inhibitors of angiotensin converting enzyme (ACE) and blockers of receptors of angiotensin (ARBS) II, which is assigned to elderly people with diseases of the cardiovascular system, increases in this category of individuals the chance of infection new coronavirus. This is stated in the study of the American Louisiana state University, which is published in the Journal of Travel Medicine.
In scientific work it is that intravenous infusion of these drugs can carry a special threat as encourage the growth of the number of cell receptors АПФ2 in the system of the pulmonary circulation of man, which, in the case of coronavirus, also bind proteins of SARS-CoV-2.
So, ACE inhibitors and ARBS can exacerbate the spread of the virus in the human body.
Since patients receiving ACE inhibitors and ARBS will have an increased number of receptors АПФ2 in their lungs, they may be at particular risk of severe disease outcomes as a result of the infections caused by SARS-CoV-2, reported in the study.
The corresponding hypothesis, as noted in the work, confirmed by the history of 1099 patients with COVID-19, who were treated in the people’s Republic of China (PRC) on December 11, 2019 January 29, 2020.